Status:
UNKNOWN
COVID19 Vaccination: Clinical, Laboratory and Cellular Monitoring
Lead Sponsor:
University of Roma La Sapienza
Collaborating Sponsors:
Istituto Superiore di Sanità
Conditions:
Health Care Utilization
Health Care Associated Infection
Eligibility:
All Genders
18-99 years
Brief Summary
Primary objective: 1\. Monitor adverse events (Adverse Event Following Immunization - AEFI) in vaccinated subjects and analyze the associations with: (a) demographic variables and anthropometric para...
Eligibility Criteria
Inclusion
- All subjects vaccinated or to be vaccinated at the AOU Policlinico Umberto I and who will agree to join the study.
Exclusion
- All subjects who refuse to give consent or who have contraindications to vaccination.
Key Trial Info
Start Date :
February 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 21 2022
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04844632
Start Date
February 11 2021
End Date
May 21 2022
Last Update
April 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Policlinico Umberto I
Roma, Italy, 00161